1-54653242-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001039464.4(MROH7):c.316G>T(p.Asp106Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000644 in 1,614,018 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001039464.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MROH7 | NM_001039464.4 | c.316G>T | p.Asp106Tyr | missense_variant | 3/24 | ENST00000421030.7 | NP_001034553.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MROH7 | ENST00000421030.7 | c.316G>T | p.Asp106Tyr | missense_variant | 3/24 | 2 | NM_001039464.4 | ENSP00000396622.2 | ||
MROH7-TTC4 | ENST00000414150.6 | n.316G>T | non_coding_transcript_exon_variant | 3/33 | 2 | ENSP00000410192.2 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000281 AC: 7AN: 249308Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135270
GnomAD4 exome AF: 0.0000657 AC: 96AN: 1461866Hom.: 0 Cov.: 48 AF XY: 0.0000729 AC XY: 53AN XY: 727240
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74328
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 30, 2022 | The c.316G>T (p.D106Y) alteration is located in exon 3 (coding exon 1) of the MROH7 gene. This alteration results from a G to T substitution at nucleotide position 316, causing the aspartic acid (D) at amino acid position 106 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at